Global pharma giants escape US regulation while testing drugs in China’s Xinjiang: Report
New Delhi, April 14 (IANS) Multinational pharmaceutical giants -- with R&D investments and human trials running in China’s Xinjiang region and at Chinese military hospitals -- are escaping US regulation that prohibits drug development or clinical testing, according to an article in The Wire, a New York-headquartered global digital magazine.